Abstract: Background: Hepatitis B Viral (HBV) infection is one of the major causes of Hepatocellular Carcinoma (HCC). Mounting evidence had provided that the HBV integration might be a critical contributor of HCC carcinogenesis.
INTRODUCTION
HBV infection is an epidemic in Asia, Africa, Southern Europe and Latin America, and HBV consists of at least eight genotypes (A-H) [1] . Several factors have been known to be related to higher HCC risk among HBV carriers: demographic (male gender, older age, ethnicity), genetic (family history of HCC), viral (high viral load, viral genotype, duration of infection, co-infection with HCV, HIV or HDV), and environmental (exposure to aflatoxin, alcohol abuse or cigarette smoking) [2, 3] . Generally, HBV is the main causative agent in the high incidence HCC areas, while HCV is the major etiological factor related to HCC in low incidence HCC areas [2, [4] [5] [6] . In addition, HDV chronic infection has been found to be associated with a worsening of HBV infection. Usually, it increased the risk of liver decompensation and Hepatocellular Carcinoma (HCC) occurrence [7] . Furthermore, HBV DNA and HBeAg were detected less frequently in anti-HD-positive than in anti-HD-negative subjects among patients with severe liver disease [8] . These findings indicated that HBV infection was closely related to HDV infection, although the mechanism kept unclear.
Among HBV genotypes, HBV/B and HBV/C are more restricted to east/south-east Asia [9] . HBV infection of these two types has been known as a leading cause for chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) in China [10] . The integration events of HBV/B and HBV/C are also frequent to be detected in the cancer tissues of HCC patients.
Massive Parallel Sequencing (MPS) technology has provided an efficient mean to detect HBV integration through whole genome. Jiang et al. investigated the effect of HBV integration by whole genome sequencing. They found that HBV integration could trigger the copy number variation of genome and induce the abnormal expression [11] . Sung et al. had surveyed the hotspot genes of HBV integration through the whole genome and determined that there was a significant relationship between HBV integration and survival time [12] . Furthermore, the researcher found that the viral-human chimeric transcript may trigger the Wnt signaling pathways and had close relation with the development and progression of liver cancer [13] . Based on the above studies, it suggested that HBV integration is an important event in the process of tumorigenesis. HBV integration can not only cause genetic damage and chromosomal instability but also cause disorder to the host gene expression [14] . In addition, expression of viral proteins such as X protein and S antigen may further induce the tumorigenesis [13] . Indeed, the first descriptions of HBV integration events were based on primary HCC tissues and HCC-derived cell lines, prompting suggestions that HBV integration events might be causative in tumorigenesis [15, 16] . Hitherto, the reported mechanisms include (1) HBV integration mediated insertional mutagenesis of HCCassociated genes; (2) induction of chromosomal instability by HBV integration; (3) the expression of HBV genes from the HBV integration. However, the mechanism of HBVinduced HCC carcinogenesis still remains unclear so far [17] .
However, the samples in these studies were collected via invasive procedures. In order to facilitate the clinical utilization, HBV integration events in plasma were urgently needed to be surveyed. The characteristic of HBV integration in the plasma might promote the clinical utilization potential of HBV integration.
A high throughput virus integration detection (HIVID) approach was adopted to investigate the HBV integration sites [18] . Overall, there were 15 samples with HBV integration among 20 plasma samples and 87 breakpoints were found in the 15 plasma samples. Furthermore, we determine the characteristic of HBV integration sites in the plasma samples. HBV integration was prone to the region of IN-TRON. Pathway analysis indicated that the HBV integration events were enriched in the pathway of cancer. Altogether, our results provided evidence for the HBV integration in these plasma samples and explored the characteristic of HBV integration in the plasma, which might be useful for HCC prognosis and diagnosis.
MATERIALS AND METHODS

Sample Collection and Plasma DNA Extraction
We obtained the plasma and tumor tissue samples from the Affiliated Hospital of Jining Medical University, Jining, China, and patients had been diagnosed with HCC. All patients signed the written informed consent form, and the study had been approved by the Ethics Review Committee in the Jining Medical University. Plasma was stored at 80°C and DNA was extracted from a 0.5-ml plasma aliquot with DNA Blood Midi Kit (Qiagen, Germany) according to the manufacturer's instructions and stored at -20°C before further analysis. The inclusion criteria for this study included: (i) HBV-positive HCCs (HBV-B type) (ii) obtained from consenting patients and (iii) all patients were HCV-negative and HIV-negative (iv) negative for autoimmune hepatitis and metabolic and/or genetic disorders, such as Wilson's disease, hemochromatosis.
HBV Fragments Enrichment and Sequencing
The construction of sequencing library strictly followed the standard instructions provided by Illumina. The cell free DNA purified, and their ends were blunted, "A" tailed, ligated to adaptors and then PCR. The DNA libraries were quantified using Bioanalyser 2100 (Agilent Technologies, Santa Clara, CA, USA). The hybridization procedures were carried out following MyGenostics's GenCapTM Target Enrichment Protocol (GenCapTM Enrichment, MyGenostics, USA). The DNA libraries were hybridized with HBV probes at 65°C for 24 hours and subsequently subjected to washes to remove unbound. The eluted fragments were amplified by 12 PCR cycles in order to generate the sequencing library. Each library was further quantified and proceeded to 101 cycles of paired-end index sequencing in the Illumina HiSeq 2000 sequencer according to the manufacturer's official instruction.
Breakpoints Detection and Annotation of HBV Integration Sites
Deploying an algorithm established by our team previously [18] , the low-quality reads, duplication reads and adaptor contaminations were removed. Subsequently, the filtered clean reads were mapped to both the human (NCBI build 37, HG19) and the HBV genomes. The chimeric reads that partially aligned to the human genome and partially aligned to the HBV genome were remained as the reads of our interest. The selected chimeric reads were then subjected to pairedend reads assembly, which helped to reconstruct fragment sequences, and additionally increased the efficacy to locate the precise position of the breakpoints. The PE-assembled reads were re-mapped to the human and the HBV genome using BWA [19] . The HBV integration breakpoints were annotated using ANNOVAR [20] .
RESULTS
The Distribution of Breakpoints in the Human Genome
Plasma samples of 20 HCC patients were obtained in order to investigate the HBV integration sites ( Table 1) . The DNA of plasma was processed according to our innovative HIVID approach [18] . Among the samples, 15 samples showed positive for HBV integration, altogether 87 integration sites were determined ( Table 2) . Among all the integration sites, 46 of them were in the intron region, and 24 were in the intergenic region (Table 3) . Therefore, it seems that the breakpoints were more prone to be enriched in the intron region ( Fig. 1a; Intron observed ratio=0.53; Intron random ratio=0.34; Chisquare Test P<0.01).
The Distribution of Breakpoints in the HBV Genome
The distribution of breakpoints in the HBV genome was then analysed. It was also revealed that the breakpoints from plasma samples were enriched in the region of 1700-2000 bp of the HBV genome specifically (Fig. 1b). 
The Pathway Analysis of Breakpoints
Using DAVID pathway enrichment software, the genes integrated by HBV were analysed [21, 22] , and the results indicated that cancer pathway was particularly targeted (P<0.01). These five genes CTNNA2, EGFR, MITF, STK36 and RALA were located in the cancer pathway. 
DISCUSSION
HBV integration had previously been demonstrated having a close association with the tumorigenesis of HCC. In the studies led by Sung et al., the authors had identified several genes preferentially integrated by HBV [12] . In this study, our team had analysed the HBV integration sites in 20 plasma samples of HCC patients. The results suggested that the genes in the cancer pathway were particularly targeted by HBV integration. In recent years, the use of plasma DNA sample in clinical diagnosis has become increasingly important [23] , this is due to the presence of circulating DNA originated from the degenerating tumor cells [24] . According to the established data, one of the major sources of plasma or serum DNA may be from the apoptotic cells [25] , though the entire mechanism of DNA being released into circulating blood still remains to be thoroughly investigated.
Generally, there was a significant portion of the cf-DNA from the tumor tissues. Many researchers have identified that common genetic alterations exist in both tumor tissue and paired plasma samples [26] . The level and characteristic of cf-DNA in human plasma have been affected by the dynamic balance between cellular DNA release and DNA degradation. Thus, stability of distinct cf-DNA forms [27, 28] , activity of blood nucleases [29] , adsorption of cf-DNA on blood cells [30, 31] , as well as degradation of cf-DNA by phagocytes should also be considered as factors regulating the characteristic and level of cf-DNA in cancer patients [32] .
Moreover, it is curious to find a number of breakpoints located in the intergenic regions. In recent years, an increasing trend of research interests had drawn to resolve the usefulness of breakpoints located in the intergenic region. For instances, MYC activation was driven by an upstream integration of HPV-18 genome [33] ; -catenin transactivity could be modulated by HBV integration in Long Interspersed Nuclear Element (LINE) [13] . Thus the importance and significance of HBV integration sites in the intergenic region remain elusive.
The distribution of breakpoints in the HBV genome was also investigated. It was revealed that the breakpoints were particularly enriched in the region of HBV X and core genes, which is in line with the previous findings by others and also our group.
CONCLUSION
Our study had adopted an effective method to seek HBV integration sites in the plasma samples. The results provided evidence for HBV integration in the plasma samples, which could be potentially useful for future HCC prognosis and diagnosis.
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